Latest Headlines

  1. Merck Launches AAW Workstation To Advance Lab Automation 7/15/2025

    Merck, a leading science and technology company, has launched the AAW Automated Assay Workstation, a solution powered by Opentrons, a leader in lab automation and accessible robotics.

  2. Immundiagnostik To Highlight Innovative Detection Tools At 2025 ADLM Clinical Lab Expo 7/15/2025

    Immundiagnostik, Inc., along with its parent company Immundiagnostik AG (Bensheim, Germany), is pleased to announce its upcoming participation at the 2025 ADLM Clinical Lab Expo in Chicago, July 29–31.

  3. Quest Diagnostics Introduces Testing For Oropouche Virus 7/15/2025

    Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced the launch of a new diagnostic laboratory test for the Oropouche virus, an emerging disease that is increasingly found in South and Central America and the Caribbean.

  4. Thermo Fisher Scientific Introduces The Oncomine Comprehensive Assay Plus On The Ion Torrent Genexus System To Help Advance The Future Of Precision Medicine 7/14/2025

    Today, Thermo Fisher Scientific announced that the Oncomine Comprehensive Assay Plus* is now available on the Ion Torrent Genexus System* helping accelerate precision oncology research. 

  5. Waters And BD's Biosciences & Diagnostic Solutions Business To Combine, Creating A Life Science And Diagnostics Leader Focused On Regulated, High-Volume Testing 7/14/2025

    Waters Corporation (NYSE: WAT) and BD (Becton, Dickinson and Company) (NYSE: BDX) today announced a definitive agreement to combine BD's Biosciences & Diagnostic Solutions business with Waters, creating an innovative life science and diagnostics leader with pioneering technologies and an industry-leading financial outlook.

  6. Quidelortho And Bühlmann Laboratories AG Announce Availability Of Fecal Calprotectin (fCAL®) Turbo And Fecal Pancreatic Elastase (fPELA®) Turbo Assays On Vitros™ Systems As A Microtip™ Partnership Assay (Mpa) 7/14/2025

    QuidelOrtho Corporation ("QuidelOrtho") and BÜHLMANN Laboratories AG today announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo assays on QuidelOrtho's VITROS Systems as an MPA.

  7. Mindpeak Joins Techcyte Fusion Partner Program To Accelerate AI-Powered Digital Pathology 7/10/2025

    Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced that its Research Use Only (RUO) platform, Techcyte Fusion, now includes Mindpeak GmbH as a partner in the Fusion Partner Program.

  8. Scopio Labs Receives Fourth FDA Clearance, Elevating Digital Morphology With Enhanced AI-Powered RBC And Platelet Capabilities 7/10/2025

    Scopio Labs, a trailblazer in Full-Field Digital Cell Morphology, today announced another significant milestone: its fourth U.S. Food and Drug Administration (FDA) clearance (K243144).

  9. Quest Diagnostics To Offer FDA-Cleared Fujirebio Blood Test For Alzheimer's Disease 7/9/2025

    Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced it plans to offer laboratory testing based on the Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test from Fujirebio, a global leader in the field of high-quality IVD testing.

  10. Claret Bioscience And Hamilton Company Partner To Automate NGS Library Prep Workflows 7/9/2025

    Claret Bioscience, a pioneer in next-generation sequencing (NGS) library preparation technologies for challenging samples, and Hamilton Company, a global leader in precision laboratory automation, are proud to announce a strategic co-promotion initiative.